Medicure Inc Cash Flow Conversion Efficiency

Latest as of June 2026: 0.033x

Medicure Inc cash flow conversion efficiency. Based on the latest financial reports, Medicure Inc (MPH) has a cash flow conversion efficiency ratio of 0.033x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$386.00K ≈ $279.23K USD) by net assets (CA$11.57 Million ≈ $8.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Medicure Inc (2000–2025)

Cash flow conversion efficiency of Medicure Inc from 2000 to 2025. This chart illustrates how Medicure Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MPH live share price for real-time trading data and today's change.

Medicure Inc Cash Flow Conversion Ratio Explained

Medicure Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Medicure Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medicure Inc ranked by their cash flow conversion efficiency. Also see Medicure Inc stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Thai Rubber Latex Group Public Company Limited
BK:TRUBB
-0.011x
Pritika Auto Industries Limited
NSE:PRITIKAUTO
0.142x
Seni Jaya Corporation Bhd
KLSE:9431
0.128x
UFO Moviez India Limited
NSE:UFO
0.129x
GLORY HEALTH IND. HD-001
F:84R
N/A
Ajinextek Co. Ltd
KQ:059120
0.056x
Far East Gold Ltd
AU:FEG
-0.093x
Inspira Technologies Oxy BHN Ltd
NASDAQ:IINN
0.001x

Annual Cash Flow Conversion Efficiency for Medicure Inc (2000–2025)

The table below shows the annual cash flow conversion efficiency of Medicure Inc from 2000 to 2025. Review MPH FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$12.91 Million
≈ $9.34 Million
CA$-560.00K
≈ $-405.10K
-0.043x -165.46%
2024-12-31 CA$20.78 Million
≈ $15.03 Million
CA$1.38 Million
≈ $996.10K
0.066x -36.58%
2023-12-31 CA$19.90 Million
≈ $14.39 Million
CA$2.08 Million
≈ $1.50 Million
0.104x +20.07%
2022-12-31 CA$21.00 Million
≈ $15.19 Million
CA$1.83 Million
≈ $1.32 Million
0.087x -59.83%
2021-12-31 CA$18.41 Million
≈ $13.32 Million
CA$3.99 Million
≈ $2.89 Million
0.217x +285.19%
2020-12-31 CA$19.15 Million
≈ $13.85 Million
CA$-2.24 Million
≈ $-1.62 Million
-0.117x +78.47%
2019-12-31 CA$26.94 Million
≈ $19.49 Million
CA$-14.64 Million
≈ $-10.59 Million
-0.543x -6219.98%
2018-12-31 CA$83.59 Million
≈ $60.47 Million
CA$742.27K
≈ $536.95K
0.009x -96.73%
2017-12-31 CA$80.71 Million
≈ $58.38 Million
CA$21.92 Million
≈ $15.86 Million
0.272x +65.07%
2016-12-31 CA$38.96 Million
≈ $28.18 Million
CA$6.41 Million
≈ $4.64 Million
0.165x +414.14%
2015-12-31 CA$4.46 Million
≈ $3.23 Million
CA$142.79K
≈ $103.30K
0.032x +126.41%
2014-12-31 CA$-3.91 Million
≈ $-2.83 Million
CA$473.97K
≈ $342.86K
-0.121x -542.33%
2013-12-31 CA$-5.88 Million
≈ $-4.25 Million
CA$110.88K
≈ $80.21K
-0.019x -108.24%
2012-12-31 CA$-4.33 Million
≈ $-3.13 Million
CA$-990.48K
≈ $-716.50K
0.229x +199.88%
2011-12-31 CA$-1.82 Million
≈ $-1.32 Million
CA$417.29K
≈ $301.86K
-0.229x -1190.93%
2010-12-31 CA$-26.89 Million
≈ $-19.45 Million
CA$477.48K
≈ $345.40K
-0.018x -130.50%
2009-12-31 CA$-24.96 Million
≈ $-18.05 Million
CA$-1.45 Million
≈ $-1.05 Million
0.058x -89.08%
2008-12-31 CA$-19.55 Million
≈ $-14.14 Million
CA$-10.42 Million
≈ $-7.54 Million
0.533x -91.65%
2007-12-31 CA$-6.56 Million
≈ $-4.74 Million
CA$-41.86 Million
≈ $-30.28 Million
6.386x +967.70%
2006-12-31 CA$34.31 Million
≈ $24.82 Million
CA$-25.25 Million
≈ $-18.26 Million
-0.736x -115.75%
2005-12-31 CA$37.17 Million
≈ $26.89 Million
CA$-12.68 Million
≈ $-9.17 Million
-0.341x +79.25%
2004-12-31 CA$7.34 Million
≈ $5.31 Million
CA$-12.07 Million
≈ $-8.73 Million
-1.644x -476.36%
2003-12-31 CA$21.57 Million
≈ $15.60 Million
CA$-6.15 Million
≈ $-4.45 Million
-0.285x +64.61%
2002-12-31 CA$4.94 Million
≈ $3.58 Million
CA$-3.98 Million
≈ $-2.88 Million
-0.806x -73.80%
2001-12-31 CA$8.99 Million
≈ $6.50 Million
CA$-4.17 Million
≈ $-3.01 Million
-0.464x +34.57%
2000-12-31 CA$3.85 Million
≈ $2.79 Million
CA$-2.73 Million
≈ $-1.97 Million
-0.709x --

About Medicure Inc

V:MPH Canada Drug Manufacturers - Specialty & Generic
Market Cap
$31.10 Million
CA$43.00 Million CAD
Market Cap Rank
#24069 Global
#891 in Canada
Share Price
CA$4.12
Change (1 day)
-2.60%
52-Week Range
CA$0.90 - CA$4.44
All Time High
CA$10.58
About

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary … Read more